Federation des caisses Desjardins du Quebec’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100
Closed -$3.48K 2549
2021
Q4
$3.48K Hold
100
﹤0.01% 2281
2021
Q3
$2.71K Hold
100
﹤0.01% 2370
2021
Q2
$2.59K Hold
100
﹤0.01% 2373
2021
Q1
$2.15K Hold
100
﹤0.01% 2322
2020
Q4
$2.15K Hold
100
﹤0.01% 2192
2020
Q3
$1.48K Buy
+100
New +$1.8K ﹤0.01% 2026
2020
Q1
Sell
-500
Closed -$8.13K 2225
2019
Q4
$8.13K Buy
+500
New +$11.8K ﹤0.01% 1934

Other funds holding ANAB

Federation des caisses Desjardins du Quebec's ANAB Position: Q1 2022 in Review

Federation des caisses Desjardins du Quebec sold out of AnaptysBio (ANAB) in Q1 2022, closing a stake of 100 shares — an estimated $3.48K sold.

Federation des caisses Desjardins du Quebec first reported a position in ANAB in Q4 2019 and held it in 7 quarters. The position peaked at $8.13K in Q4 2019. 131 funds tracked by Wall St. Rank hold ANAB as of Q1 2022.

  • Federation des caisses Desjardins du Quebec reported no remaining AnaptysBio position as of Q1 2022 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 100 AnaptysBio shares in Q1 2022, an estimated $3.48K.
  • Federation des caisses Desjardins du Quebec first reported a position in AnaptysBio in Q4 2019 and held it in 7 quarters.
  • Federation des caisses Desjardins du Quebec's AnaptysBio position peaked at $8.13K in Q4 2019.
  • 131 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2022.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2022, filed 15 Aug 2024.